Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
Expert Opinion on Drug Metabolism & Toxicology
|
October 15, 2011
Triazole antifungal agents drug-drug interactions involving hepatic cytochrome P450
Paul O Gubbins
Current Opinion in Infectious Diseases
|
November 3, 2007
Mould-active azoles: pharmacokinetics, drug interactions in neutropenic patients
Paul O Gubbins
Mycoses
|
December 17, 2009
Clinically relevant drug interactions of current antifungal agents
Paul O Gubbins, Seth Heldenbrand
Current Infectious Disease Reports
|
October 9, 2015
The Influence of Influenza and Pneumococcal Vaccines on Community-Acquired Pneumonia (CAP) Outcomes Among Elderly Patients
Paul O Gubbins, Chenghui Li
Expert Opinion on Drug Metabolism & Toxicology
|
October 13, 2017
Pharmacogenomics of triazole antifungal agents: implications for safety, tolerability and efficacy
Jarrett R Amsden, Paul O Gubbins
Expert Opinion on Pharmacotherapy
|
October 13, 2005
Drug-drug interactions of antifungal agents and implications for patient care
Paul O Gubbins, Jarrett R Amsden
Currents in Pharmacy Teaching & Learning
|
September 17, 2023
Future leaders in pharmacy (FLIP): Student perceptions of leadership development within pharmacy school
Emily Eddy, Paul O Gubbins, Lisa Cillessen
Pharmacotherapy
|
March 16, 2005
Tick-borne bacterial, rickettsial, spirochetal, and protozoal infectious diseases in the United States: a comprehensive review
Jarrett R Amsden, Scott Warmack, Paul O Gubbins
Currents in Pharmacy Teaching & Learning
|
November 6, 2019
Development, implementation and perceived benefits of student pharmacist learning experiences in transitions of care
Heather Taylor, Elizabeth F Englin, Paul O Gubbins
Journal of Hospital Medicine
|
February 14, 2015
Prior pneumococcal and influenza vaccinations and in-hospital outcomes for community-acquired pneumonia in elderly veterans
Chenghui Li, Paul O Gubbins, Guoqing J Chen
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
Expert Opinion on Drug Metabolism & Toxicology
|
October 15, 2011
Triazole antifungal agents drug-drug interactions involving hepatic cytochrome P450
Paul O Gubbins
Current Opinion in Infectious Diseases
|
November 3, 2007
Mould-active azoles: pharmacokinetics, drug interactions in neutropenic patients
Paul O Gubbins
Mycoses
|
December 17, 2009
Clinically relevant drug interactions of current antifungal agents
Paul O Gubbins, Seth Heldenbrand
Current Infectious Disease Reports
|
October 9, 2015
The Influence of Influenza and Pneumococcal Vaccines on Community-Acquired Pneumonia (CAP) Outcomes Among Elderly Patients
Paul O Gubbins, Chenghui Li
Expert Opinion on Drug Metabolism & Toxicology
|
October 13, 2017
Pharmacogenomics of triazole antifungal agents: implications for safety, tolerability and efficacy
Jarrett R Amsden, Paul O Gubbins
Expert Opinion on Pharmacotherapy
|
October 13, 2005
Drug-drug interactions of antifungal agents and implications for patient care
Paul O Gubbins, Jarrett R Amsden
Currents in Pharmacy Teaching & Learning
|
September 17, 2023
Future leaders in pharmacy (FLIP): Student perceptions of leadership development within pharmacy school
Emily Eddy, Paul O Gubbins, Lisa Cillessen
Pharmacotherapy
|
March 16, 2005
Tick-borne bacterial, rickettsial, spirochetal, and protozoal infectious diseases in the United States: a comprehensive review
Jarrett R Amsden, Scott Warmack, Paul O Gubbins
Currents in Pharmacy Teaching & Learning
|
November 6, 2019
Development, implementation and perceived benefits of student pharmacist learning experiences in transitions of care
Heather Taylor, Elizabeth F Englin, Paul O Gubbins
Journal of Hospital Medicine
|
February 14, 2015
Prior pneumococcal and influenza vaccinations and in-hospital outcomes for community-acquired pneumonia in elderly veterans
Chenghui Li, Paul O Gubbins, Guoqing J Chen
Page
of 4